
![]()
Novartis Oncology in Latvia
About Novartis Oncology Latvia
Novartis Oncology mission is to become the world's premier oncology company by consistently discovering, developing, and producing broadly available novel therapies that improve and extend the lives of cancer patients. Every day, around the world we are exploring and pioneering new treatments that are likely to transform the way cancer is treated. Novartis Oncology Latvia support healthcare, educational and patient organizations' projects.
Novartis Oncology Leading Brands
Exjade® (deferasirox)
Femara® (letrozole)
Glivec® (imatinib mesylate)
Sandostatin® LAR® (octreotide)
Zometa® (zoledronic acid)
Contact Information
Address:
Brivibas gatve 214b, Riga, LV-1039
Telephone: (371) 67887070
Fax: (371) 67887077
Par Novartis Oncology Latvija
Novartis Oncology misija ir klut par pasaule vadošo kompaniju onkologijas nozare nepartraukti atklajot, attistot un ražojot plaši pieejamus un inovativus produktus, kuri uzlabo un pagarina dzivi pacientiem ar laundabigam saslimšanam. Katru dienu visa pasaule mes turpinam atklat un ieviest jaunas laundabigo saslimšanu arstešanas iespejas. Novartis Oncology Latvija atbalsta veselibas aprupes, izglitibas, ka ari pacientu organizaciju projektus.
Novartis Oncology vadošie produkti
Exjade® (deferasirox)
lieto asins parliešanas izraisitas hroniskas dzelzs parslodzes arstešanai
http://www.exjade.com
http://www.novartisoncology.com/page/exjade.jsp
Femara® (letrozole)
lieto dažu kruts veža formu arstešanai
http://www.femara.com/
http://www.novartisoncology.com/page/femara.jsp
Glivec® (imatinib mesylate)
lieto dažadu laundabigu saslimšanu arstešanai
http://www.glivec.com/
http://www.novartisoncology.com/page/glivec.jsp
Sandostatin® LAR® (octreotide)
lieto dažu endokrinas sistemas audzeju arstešanai
http://www.sandostatin.com/
http://www.novartisoncology.com/page/sandostatin.jsp
Zometa® (zoledronic acid)
lieto ar skeleta sistemu saistitu patologiju profilaksei pacientiem ar metastatiskam laundabigam patologijam, kas skar kaulus
http://www.zometa.com/
http://www.novartisoncology.com/page/zometa.jsp
Kontaktinformacija
Adrese:
Brivibas gatve 214b, Riga, LV-1039
Talrunis: (371) 67887070
Fakss: (371) 67887077
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
CAREERS AT NOVARTIS

Our success depends entirely on the creativity, performance and achievement of our associates at all levels.
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.
STAY CONNECTED TO THE CANCER RESOURCE CENTER
Receive "Oncology in the News" by email weekly.